LDHA and cancer: Anti-cancer potential of MET has gained increasing interest due to its inhibition of CSCs (Saini & Yang, 2018), as well as the reports that MET significantly down-regulated the proportion of ALDH+ CSCs subpopulation and enhanced the sensitivity of cancer cells to the DDP in advanced epithelial ovarian cancer (Kim et al., 2019).